Trademark Attorney / Law Firm
Anna Erenburg, Esq. – Trademark Portfolio
Anna Erenburg, Esq. has filed 18 trademarks with the United States Patent and Trademark Office (USPTO). Filing records are from 2006. The portfolio covers 12 Nice Classification classes, with the highest concentration in Class 5 (Pharmaceuticals, 6 filings) and Class 18 (Leather Goods, 3 filings).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Anna Erenburg, Esq.'s trademark practice covers 12 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademark applications has Anna Erenburg, Esq. filed?
Anna Erenburg, Esq. has filed 18 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does Anna Erenburg, Esq. specialize in?
Anna Erenburg, Esq. has filed trademarks across 12 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 18 (Leather Goods), Class 25 (Clothing), Class 41 (Education & Entertainment), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Anna Erenburg, Esq.'s trademark registration success rate?
Anna Erenburg, Esq. has a 0% trademark registration rate, with 0 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.